Cochlear Limited (CHEOY)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
As of 11:35AM EST. Market open.
| Previous close | 71.25 |
| Open | 69.41 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 69.17 - 69.96 |
| 52-week range | 68.95 - 94.21 |
| Volume | |
| Avg. volume | 2,203 |
| Market cap | 9.203B |
| Beta (5Y monthly) | 0.29 |
| PE ratio (TTM) | 39.05 |
| EPS (TTM) | 1.79 |
| Earnings date | N/A |
| Forward dividend & yield | 0.96 (1.35%) |
| Ex-dividend date | 22 Sept 2021 |
| 1y target est | N/A |
- Simply Wall St.
Cochlear (ASX:COH) Will Want To Turn Around Its Return Trends
If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...
- PR Newswire
FDA approves Cochlear Nucleus Implants for unilateral hearing loss/single-sided deafness
Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, obtained U.S. Food and Drug Administration (FDA) approval of Cochlear™ Nucleus® Implants for the treatment of unilateral hearing loss (UHL)/single-sided deafness (SSD).
- Simply Wall St.
Is Cochlear Limited (ASX:COH) Popular Amongst Institutions?
The big shareholder groups in Cochlear Limited ( ASX:COH ) have power over the company. Institutions often own shares...
© 2022 Yahoo. All rights reserved.
